• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    Echo Therapeutics, Inc. (ECTE)

    -NasdaqCM
    2.02 Up 0.01(0.50%) 3:46PM EST
    Add to Portfolio
    Prev Close:2.01
    Open:2.07
    Bid:2.02 x 6200
    Ask:2.03 x 6100
    1y Target Est:2.00
    Beta:1.83
    Next Earnings Date:N/A
    Day's Range:1.98 - 2.07
    52wk Range:0.39 - 3.68
    Volume:32,338
    Avg Vol (3m):92,340
    Market Cap:25.51M
    P/E (ttm):N/A
    EPS (ttm):-1.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ECTE

    Comparison

    Symbol% ChgMkt Cap
    ECTEUp 0.50%25.51M
    ABTDown 0.62%65.37B
    DXCMDown 2.78%4.64B
    MDTDown 2.46%72.26B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,471.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.19
    Quarterly EPS Est (Dec-14) :-0.32
    Mean Recommendation*:5.0
    PEG Ratio (5 yr expected):-0.04

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Echo Therapeutics, Inc. is engaged in the development of transdermal skin permeation and diagnostic medical devices. It is developing Symphony CGM system (Symphony), a needle-free wireless continuous glucose monitoring system for use in hospital c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback